Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, June 7, 2021
[ Mon, Jun 07th 2021
] - WOPRAI
[ Mon, Jun 07th 2021
] - WOPRAI
[ Mon, Jun 07th 2021
] - WOPRAI
[ Mon, Jun 07th 2021
] - WOPRAI
[ Mon, Jun 07th 2021
] - WOPRAI
[ Mon, Jun 07th 2021
] - WOPRAI
[ Mon, Jun 07th 2021
] - WOPRAI
[ Mon, Jun 07th 2021
] - WOPRAI
[ Mon, Jun 07th 2021
] - WOPRAI
[ Mon, Jun 07th 2021
] - WOPRAI
[ Mon, Jun 07th 2021
] - WOPRAI
[ Mon, Jun 07th 2021
] - WOPRAI
[ Mon, Jun 07th 2021
] - WOPRAI
[ Mon, Jun 07th 2021
] - WOPRAI
[ Mon, Jun 07th 2021
] - WOPRAI
[ Mon, Jun 07th 2021
] - WOPRAI
[ Mon, Jun 07th 2021
] - WOPRAI
[ Mon, Jun 07th 2021
] - WOPRAI
[ Mon, Jun 07th 2021
] - WOPRAI
[ Mon, Jun 07th 2021
] - WOPRAI
[ Mon, Jun 07th 2021
] - WOPRAI
[ Mon, Jun 07th 2021
] - WOPRAI
[ Mon, Jun 07th 2021
] - WOPRAI
[ Mon, Jun 07th 2021
] - WOPRAI
Fri, June 4, 2021
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
[ Fri, Jun 04th 2021
] - WOPRAI
Andrew Fein Initiated (CCCC) at Strong Buy and Held Target at $63 on, Jun 4th, 2021
Andrew Fein of HC Wainwright & Co., Initiated "C4 Therapeutics, Inc." (CCCC) at Strong Buy and Held Target at $63 on, Jun 4th, 2021.
Andrew has made no other calls on CCCC in the last 4 months.
There is 1 other peer that has a rating on CCCC. Out of the 1 peers that are also analyzing CCCC, 0 agree with Andrew's Rating of Hold.
This is the rating of the analyst that currently disagrees with Andrew
- Matthew Luchini of "BMO Capital" Initiated at Buy and Held Target at $55 on, Wednesday, March 31st, 2021
